Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Rajith Bhaskaran
Observed names:
Bhaskaran, Rajith,
R Bhaskaran,
R. Bhaskaran
Institution:
Agendia (Netherlands)
Observed institutions:
Skolkovo Institute of Science and Technology,
The Netherlands Cancer Institute,
Princess Máxima Center,
Agendia (Netherlands)
ORCID:
0000-0001-8710-2373
Observed ORCID:
0000-0001-8710-2373
OpenAlex ID:
A5110640720
SOX2 Is the Determining Oncogenic Switch in Promoting Lung Squamous Cell Carcinoma from Different Cells of Origin
2016
·
Giustina Ferone
, Ji-Ying Song
, et al.
·
Cancer Cell
·
249
PDF
Transcription Factor NFIB Is a Driver of Small Cell Lung Cancer Progression in Mice and Marks Metastatic Disease in Patients
2016
·
Ekaterina A. Semenova
, Min-chul Kwon
, et al.
·
Cell Reports
·
157
PDF
Tumor Heterogeneity Underlies Differential Cisplatin Sensitivity in Mouse Models of Small-Cell Lung Cancer
2019
·
Franziska Böttger
, Ekaterina A. Semenova
, et al.
·
Cell Reports
·
62
PDF
TRIM28 haploinsufficiency predisposes to Wilms tumor
2019
·
Illja J. Diets
, Juliane Hoyer
, et al.
·
International Journal of Cancer
·
60
PDF
Combined deletion of Bap1 , Nf2 , and Cdkn2ab causes rapid onset of malignant mesothelioma in mice
2020
·
Jitendra Badhai
, Gaurav Kumar Pandey
, et al.
·
The Journal of Experimental Medicine
·
49
MammaPrint and BluePrint comprehensively capture the cancer hallmarks in early‐stage breast cancer patients
2021
·
Josien C. Haan
, Rajith Bhaskaran
, et al.
·
Genes Chromosomes and Cancer
·
42
Tumor-infiltrating lymphocytes in HER2-positive breast cancer treated with neoadjuvant chemotherapy and dual HER2-blockade
2024
·
M. C. Liefaard
, A. van der Voort
, et al.
·
npj Breast Cancer
·
35
PDF
B-cells and regulatory T-cells in the microenvironment of HER2+ breast cancer are associated with decreased survival: a real-world analysis of women with HER2+ metastatic breast cancer
2023
·
Tessa G. Steenbruggen
, Denise M. Wolf
, et al.
·
Breast Cancer Research
·
17
PDF
Gene expression regulation by the Chromodomain helicase DNA-binding protein 9 (CHD9) chromatin remodeler is dispensable for murine development
2020
·
Andrej Alendar
, Jan-Paul Lambooij
, et al.
·
PLoS ONE
·
16
PDF
A natural WNT signaling variant potently synergizes with Cdkn2ab loss in skin carcinogenesis
2019
·
Paul Krimpenfort
, Margriet Snoek
, et al.
·
Nature Communications
·
15
PDF
BluePrint breast cancer molecular subtyping recognizes single and dual subtype tumors with implications for therapeutic guidance
2022
·
Midas M. Kuilman
, Architha Ellappalayam
, et al.
·
Breast Cancer Research and Treatment
·
12
PDF
BluePrint molecular subtyping recognizes single and dual subtype tumors with consequences for therapeutic guidance
2020
·
M. Kuilman
, A. Ellappalayam
, et al.
·
European Journal of Cancer
·
7
Characterization of the Tumor Microenvironment of De Novo Oligometastatic Breast Cancer in a Nationwide Cohort
2023
·
Tessa G. Steenbruggen
, Denise M. Wolf
, et al.
·
JCO Precision Oncology
·
3
PDF
Prediction of Benefit From Adjuvant Pertuzumab by 80-Gene Signature in the APHINITY (BIG 4-11) Trial
2024
·
Ian E. Krop
, Lorenza Mittempergher
, et al.
·
JCO Precision Oncology
·
2
An expanded 29-gene HER2 signature robustly identifies genomic HER2-Type early-stage breast tumors
2022
·
A. Ellappalayam
, A. Barcaru
, et al.
·
European Journal of Cancer
·
1
Corrigendum to “518 Poster - BluePrint molecular subtyping recognizes single and dual subtype tumors with consequences for therapeutic guidance” [Eur J Cancer 138 (Supplement 1) (October 2020) S106–S107]
2022
·
Midas M. Kuilman
, Architha Ellappalayam
, et al.
·
European Journal of Cancer
·
1
161P MammaPrint and BluePrint diagnostic tests can be robustly assessed on Whole-Transcriptome NGS platform
2022
·
M.C. Liefaard
, R. Bhaskaran
, et al.
·
Annals of Oncology
·
1
220P Annotating MammaPrint and BluePrint gene profile to the Hallmarks of cancer and understanding the biology of MammaPrint extreme risk groups
2020
·
J.C. Haan
, R. Bhaskaran
, et al.
·
Annals of Oncology
·
1
PDF
High-risk breast cancer genes at 8q22-24 and their role in over 5,000 patients evaluated with the 70-gene risk of recurrence assay.
2020
·
Sami Diab
, Matei P. Socoteanu
, et al.
·
Journal of Clinical Oncology
·
1
PO-223 Modelling malignant mesothelioma in mice: a critical role for BAP1 loss
2018
·
J. Badhai
, R. Bhaskaran
, et al.
·
ESMO Open
·
1
PO-338 Tumour heterogeneity underlies differential cisplatin sensitivity in mouse models of SCLC
2018
·
E. Semenova
, F. Böttger
, et al.
·
ESMO Open
·
1
Abstract PS7-69: Molecular profiles and clinical-pathological features of Asian early-stage breast cancer patients
2021
·
Margaret Chen
, Ava Kwong
, et al.
·
Cancer Research
Unravelling the biological characteristics of MammaPrint ultra-low risk group
2020
·
JC Haan
, R Bhaskaran
, et al.
·
Geburtshilfe und Frauenheilkunde
Abstract P4-10-24: Cyclin E overexpression is associated with high risk 70 gene signature, and may indicate intrinsic resistance to CDK4/6 inhibitors
2020
·
Lorenza Mittempergher
, Joe McKelley
, et al.
·
Cancer Research
Unravelling the biological characteristics of MammaPrint extreme risk subgroups
2019
·
R. Bhaskaran
, C. Griffioen
, et al.
·
Annals of Oncology
Show more works
View as search
Works count:
36
Citation count:
733
H-index:
11
I10-index:
11
Year
Topic
Type
